Silver nitrate

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Brand Names
Styptstix
Generic Name
Silver nitrate
DrugBank Accession Number
DB11080
Background

Silver nitrate is an inorganic compound with the chemical formula AgNO3. In its solid form, silver nitrate is coordinated in a trigonal planar arrangement. It is often used as a precursor to other silver-containing compounds. It is used in making photographic films, and in laboratory setting as a staining agent in protein visualization in PAGE gels and in scanning electron microscopy.

Type
Small Molecule
Groups
Approved, Investigational
Structure
Weight
Average: 169.8731
Monoisotopic: 168.892910891
Chemical Formula
AgNO3
Synonyms
  • Nitrate d'argent
  • Nitrato de plata
  • Silver mononitrate
  • Silver nitrate
  • silver(1+) nitrate
External IDs
  • Caswell No. 737
  • UN1493

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Therapies
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
No interactions found.

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Active Moieties
NameKindUNIICASInChI Key
Silver cationionic57N7B0K90A14701-21-4FOIXSVOLVBLSDH-UHFFFAOYSA-N
International/Other Brands
Avoca
Brand Name Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Avoca Flexible Caustic ApplicatorStick30 mg/40mgTopicalBray Group Limited1925-04-01Not applicableUS flag
Silver NitrateLiquid0.25 g/10gTopicalGordon Laboratories2010-07-14Not applicableUS flag
Silver NitrateLiquid0.025 g/1gTopicalGordon Laboratories2010-07-15Not applicableUS flag
Silver NitrateSolution0.005 g/1mLTopicalTeva Pharmaceuticals USA, Inc.1991-01-01Not applicableUS flag
Silver NitrateLiquid0.1 g/10gTopicalGordon Laboratories2010-07-14Not applicableUS flag
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Anti-bacterial SlimeGel0.005 g/100gTopicalDongguan City Dexu Toys Co., Ltd.2020-03-30Not applicableUS flag
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Silver Nitrate ApplicatorsSilver nitrate (75 mg/1) + Potassium nitrate (25 mg/1)SwabTopicalMcKesson Medical-Surgical2017-07-012018-08-16US flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Anti-bacterial SlimeSilver nitrate (0.005 g/100g)GelTopicalDongguan City Dexu Toys Co., Ltd.2020-03-30Not applicableUS flag
Avoca Flexible Caustic ApplicatorSilver nitrate (30 mg/40mg)StickTopicalBray Group Limited1925-04-01Not applicableUS flag
Grafco Applicator 15 CmSilver nitrate (38.21 mg/1) + Potassium nitrate (12.74 mg/1)StickTopicalGf Health Products, Inc.1949-04-19Not applicableUS flag
Grafco Applicator 30 CmSilver nitrate (52.451 mg/1) + Potassium nitrate (17.486 mg/1)StickTopicalGf Health Products, Inc.1949-04-19Not applicableUS flag
Grafco Applicator 45 CmSilver nitrate (73.4314 mg/1) + Potassium nitrate (24.4804 mg/1)StickTopicalGf Health Products, Inc.1949-04-19Not applicableUS flag

Categories

ATC Codes
D08AL01 — Silver nitrate
Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of inorganic compounds known as transition metal nitrates. These are inorganic compounds in which the largest oxoanion is nitrate, and in which the heaviest atom not in an oxoanion is a transition metal.
Kingdom
Inorganic compounds
Super Class
Mixed metal/non-metal compounds
Class
Transition metal oxoanionic compounds
Sub Class
Transition metal nitrates
Direct Parent
Transition metal nitrates
Alternative Parents
Inorganic silver salts / Inorganic oxides
Substituents
Inorganic oxide / Inorganic salt / Inorganic silver salt / Transition metal nitrate
Molecular Framework
Not Available
External Descriptors
silver salt, inorganic nitrate salt (CHEBI:32130)
Affected organisms
Not Available

Chemical Identifiers

UNII
95IT3W8JZE
CAS number
7761-88-8
InChI Key
SQGYOTSLMSWVJD-UHFFFAOYSA-N
InChI
InChI=1S/Ag.NO3/c;2-1(3)4/q+1;-1
IUPAC Name
silver(1+) nitrate
SMILES
[Ag+].[O-]N(=O)=O

References

General References
Not Available
KEGG Drug
D01730
PubChem Compound
516904
PubChem Substance
347827888
ChemSpider
22878
RxNav
9789
ChEBI
32130
ChEMBL
CHEMBL177367
Wikipedia
Silver_nitrate

Clinical Trials

Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package
PhaseStatusPurposeConditionsCountStart DateWhy Stopped100+ additional columns
Not AvailableCompletedTreatmentEpidermal Growth Factor Receptor Inhibitor / Nail infection1somestatusstop reasonjust information to hide
4CompletedTreatmentGranuloma / Tracheostomy care1somestatusstop reasonjust information to hide
4Unknown StatusPreventionGastrocutaneous Fistula / Gastrostomy Complications1somestatusstop reasonjust information to hide
4Unknown StatusTreatmentHypergranulation Tissue; Gastrostomy Tube Site1somestatusstop reasonjust information to hide
4Unknown StatusTreatmentPilonidal Sinus of Natal Cleft / Pilonidal Sinus Without Abscess1somestatusstop reasonjust information to hide

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
GelTopical0.005 g/100g
StickTopical30 mg/40mg
StickTopical
LiquidTopical0.025 g/1g
LiquidTopical0.1 g/10g
LiquidTopical0.25 g/10g
SolutionTopical0.005 g/1mL
SwabTopical75 mg/1mg
SwabTopical
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
logP0.028Chemaxon
pKa (Strongest Acidic)-1.4Chemaxon
pKa (Strongest Basic)-10Chemaxon
Physiological Charge-1Chemaxon
Hydrogen Acceptor Count3Chemaxon
Hydrogen Donor Count0Chemaxon
Polar Surface Area68.88 Å2Chemaxon
Rotatable Bond Count0Chemaxon
Refractivity9.85 m3·mol-1Chemaxon
Polarizability3.24 Å3Chemaxon
Number of Rings0Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-01b9-0900000000-0bba9ddddd4bd74a59cc
Chromatographic Properties
Collision Cross Sections (CCS)
Not Available

Drug created at December 03, 2015 16:51 / Updated at September 28, 2021 21:54